ENvue Medical Resumes PainShield Shipments After U.S. Manufacturing Transition
Event summary
- ENvue Medical resumed U.S. commercial shipments of PainShield on September 9, 2026, following the transfer of manufacturing from Israel to the U.S.
- The company began fulfilling open orders from its exclusive U.S. distributor, Ultra Pain Products, Inc.
- PainShield is a wearable, non-invasive therapeutic ultrasound device for pain treatment, available by prescription in the U.S.
- ENvue Medical aims to strengthen supply continuity and streamline operations with the U.S. manufacturing transition.
The big picture
ENvue Medical's resumption of PainShield shipments marks a critical operational milestone following its manufacturing transition. The move aligns with broader industry trends toward domestic production to mitigate supply chain risks. The company's ability to support its distribution partners and meet customer demand will be key to sustaining growth in the competitive medical device market.
What we're watching
- Supply Chain Stability
- How ENvue Medical will maintain U.S. manufacturing operations and ensure supply continuity for PainShield.
- Market Demand
- Whether the company can meet customer demand and rebuild growth in the NanoVibronix business.
- Operational Efficiency
- The pace at which ENvue Medical achieves anticipated operational efficiencies from U.S. manufacturing.